Skip to main content

Table 1 Age, sex, and cytomegalovirus (CMV) seropositivity for age groups and vaccine response groups

From: CD31 + naïve T cells associate with immunosenescence and responsiveness to multiple vaccines in older adults

Age groups

median age (range)

age p-value

CMV seropositivity % (n)

CMV p-value

male % (n)

sex p-value

N

young adults (YA)

29 (25–48)

YA-MA: 0.011

43 (3)

YA-MA: 0.062

29 (2)

YA-MA: 0.061

7

middle aged adults (MA)

60 (55–62)

MA-OA: 0.002

62 (5)

MA-OA: 0.010

50 (4)

MA-OA: 0.067

8

older adults (OA)

72 (65–77)

OA-YA: <0.0001

62 (10)

OA-YA: 0.065

62 (10)

OA-YA: 0.019

16

all

65 (25–77)

 

58 (18)

 

52 (16)

 

31

Vaccine response groups

median age (range)

age p-value

CMV seropositivity % (n)

CMV p-value

male % (n)

sex p-value

N

low responders (LR)

69 (39–76)

LR-HR: 0.068

65 (11)

LR-HR: 0.065

65 (11)

LR-HR: 0.210

17

high responders (HR)

60 (25–77)

 

50 (7)

 

36 (5)

 

14